HHS tallies remdesivir allocations to states, territories
For three weeks, beginning May 4 and ending May 24, the Department of Health and Human Services said it delivered to states, territories and government agencies more than 12,000 cases of 40 vials each of remdesivir to help treat COVID-19 infections.
Every state and territory has received at least one shipment, and hospitals are asked to continue inputting data for future allocations. The administration said 80% of the allocated drugs was based on the number of confirmed or suspected COVID-19 cases reported in the TeleTracking platform. Less than 10% of Gilead Sciences Inc.’s original 600,000 vial donation is being held for emerging hotspots, and Gilead said it plans to donate an additional 330,000 vials by the end of June.
Related News Articles
Headline
A study published Aug. 5 by Nature found that COVID-19 infection can reactivate dormant, chronic viruses such as Epstein-Barr and cytomegalovirus. The study…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…